LifeNet Health Unveils Dermacell Porous: A New Era in Chronic Wound Healing Backed by Medicare LCD Coverage
Virginia Beach, VA April 2025 – LifeNet Health a global leader in regenerative medicine, has announced the launch of Dermacell Porous a groundbreaking skin substitute engineered to accelerate the healing of chronic wounds, particularly those resistant to conventional treatment. Designed to close wounds in four or fewer applications, Dermacell Porous has been selected as one of 26 skin substitute grafts and CTPs to be covered under Medicare’s new Local Coverage Determinations taking effect on January 1, 2026.

Dermacell Porous combines clinical innovation with regulatory readiness, making it a vital addition to clinicians wound care arsenal

Setting a New Clinical Standard
The promise of Dermacell Porous lies in its intelligent design and biological performance. Created using LifeNet Health’s proprietary Matracell decellularization technology, it retains the complete extracellular matrix including collagen, elastin, growth factors, and cytokines which supports cellular ingrowth and tissue regeneration.

We applied Dermacell Porous to a deep diabetic wound that had resisted healing. In just three weeks, it was fully closed, said Dr. Kenny Luong, DPM, FACFAS, underscoring its rapid and effective healing potential.

Clinical data continues to support Dermacell’s performance:

135 parcentage higher healing rates

148 parcentage greater wound reduction compared to traditional dressings

An 84 parcentagelower amputation rate in Wagner Grade 3 and 4 wounds

Dermacell Porous offers not just a scaffold, but a biologically active healing environment, noted Dr. Loan Lam, Medical Director of Wound Services at United Vein & Vascular Centers, who led one of the first clinical implementations. We are seeing more predictable and faster healing across complex cases.

Designed for Efficiency and Safety
In addition to clinical strength, Dermacell Porous provides ease of use for healthcare providers:

Non-sided design for simplified application

Sterile with validated viral inactivation

Room temperature shelf stability

Ready to use straight from the package

These features reduce storage and handling burdens while enhancing safety for patients and clinicians alike.

A Milestone in Accessibility
The inclusion of Dermacell Porous in Medicare’s upcoming LCD coverage marks a significant milestone. As wound care costs continue to rise, accessible and effective solutions are critical to improving patient outcomes and reducing the burden on the healthcare system.

This is more than just a product launch it’s a leap forward in accessibility and healing, said Daniel Osborne, Chief Growth Officer at LifeNet Health. We are committed to expanding regenerative care access for all patients, and Dermacell Porous embodies that mission.

About LifeNet Health
LifeNet Health is a nonprofit organization dedicated to saving lives, restoring health, and giving hope through organ and tissue donation, research, and regenerative therapies. With over 40 years of experience, LifeNet Health continues to lead in biologics innovation, offering clinicians cutting-edge tools to meet the most complex medical challenges.